1. Medtech Insight

University Of Cambridge Project Nimble Genomics Discusses Brain Cancer Liquid Biopsy

 
• By Natasha Barrow

University of Cambridge's soon-to-be spun-out Nimble Genomics is among grant-winning projects in Capital Enterprise's Cancer Tech Accelerator. Medtech Insight spoke to clinical oncologist and Nimble founder Henno Martin and co-founder Radek Lach to learn more what about the brain cancer blood test’s prospects in an increasingly competitive liquid biopsy space.

Liquid Biopsy
Liquid Biopsy (Shutterstock)

Liquid biopsy innovator Nimble Genomics “will transform the diagnosis and stratification of cancers, including brain cancers,” said co-founder Henno Martin, opening the company’s pitch at the Cancer Tech Accelerator Demo Day held on 24 October by European intellectual property firm HGF.

“Around 1,400 patients are diagnosed with low-grade glioma every year in the UK. Often, the diagnosis is delayed due to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Startups & SMEs

More from In Vitro Diagnostics